ramdesivir
-
Jubilant Pharmova’s subsidiary, Jubilant Pharma, announces the development of a novel oral formulation of Remdesivir with successful completion of safety and pharmacokinetic/absorption studies in animals and healthy human volunteers
India – April 19 2021 – Jubilant Pharma Limited, a subsidiary of Jubilant Pharmova Limited, announces successful completion of safety…
Read More »